NCT06048172 Effectiveness of Trauma Therapy Using Prolonged Exposure for Patients With PTSD and a Comorbid Psychotic Disorder
| NCT ID | NCT06048172 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medicalschool Hamburg |
| Condition | Post Traumatic Stress Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2023-05-15 |
| Primary Completion | 2028-05-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2023-05-15 with a primary completion date of 2028-05-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Psychosis patients with comorbid PTSD will be treated with trauma therapy.
Eligibility Criteria
Inclusion Criteria: * Presence of a psychotic disorder (F20) or affective disorder with psychotic symptoms(F30) according to DSM-5. * comorbid post-traumatic stress disorder (PTSD) according to DSM-5 (CAPS-5 score ≥ 23) * At least 18 years old * Good knowledge of the German language * Willingness to participate in randomisation and trauma-focused therapy Exclusion Criteria: * Changes in neuroleptic or antidepressant therapy within the last 4 weeks (exclusion of drug effects). * Any substance dependence with continued use other than nicotine and/or caffeine dependence. * IQ of 70 or less * Acute suicidality * Pregnant women
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06048172 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Post Traumatic Stress Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06048172 currently recruiting?
Yes, NCT06048172 is actively recruiting participants. Contact the research team at susanne.sarkar@hafencity-institut-psychotherapie.de for enrollment information.
Where is the NCT06048172 trial being conducted?
This trial is being conducted at Hamburg, Germany.
Who is sponsoring the NCT06048172 clinical trial?
NCT06048172 is sponsored by Medicalschool Hamburg. The trial plans to enroll 56 participants.